Temporary Change in Status for the Stimulants Drug Class

April 23, 2020

HHSC has been informed of a drug shortage for Methylphenidate ER in the Stimulants drug class. VDP temporarily removed the non-preferred status from the brand formulations of the NDCs below on April 23. These changes will allow providers to prescribe for these drugs without requiring a PDL prior authorization and allow continued access to necessary medication for clients. This is a temporary change until the preferred products are sufficiently available in the market. VDP will announce any further PDL status changes of these NDCs. Contact vdp-formulary@hhsc.state.tx.us for more information.